QX 314,
QX-314,
QX-314 bromide,
QX-314,
Lidocaine N-ethyl bromide,
QX 314 bromide,
Lidocaine N-ethyl bromide quaternary salt,
21306-56-9,
24003-58-5,
N-(2,6-Dimethylphenylcarbamoylmethyl)triethylammonium bromide,
SR-01000075323,
MLS000859919,
SCHEMBL746069,
QX-314.Br,
CHEMBL1255750,
CTK8G2715,
DLHMKHREUTXMCH-UHFFFAOYSA-N,
HMS1361J13,
HMS2235P07,
HMS3262G19,
HMS3267O03,
HMS3370A05,
HMS3402J13,
HMS3675P16,
Tox21_500679,
BN0435,
AKOS024456333,
CCG-221983,
LP00679,
MB00591,
ACM21306569,
NCGC00094039-01,
NCGC00094039-02,
NCGC00261364-01,
BC600134,
SMR000326780,
B6547,
EU-0100679,
FT-0748930,
L 5783,
C-55151,
J-013978,
SR-01000075323-1,
SR-01000075323-3,
{[(2,6-dimethylphenyl)carbamoyl]methyl}triethylazanium bromide,
Lidocaine N-ethyl bromide, analytical standard, for drug analysis,
2-(2,6-DIMETHYLPHENYLAMINO)-N,N,N-TRIETHYL-2-OXOETHANAMINIUM BROMIDE,
D0K6YK,
IN1130,
QX 314,
CID9884487,
IN-1130,